Abstracts

Mitochondrial DNA Haplogroups and Neurocognitive Impairment in the CHARTER Cohort

Background: Neurocognitive impairment (NCI) remains an important complication of HIV infection in the combination antiretroviral therapy (CART) era. Mitochondrial DNA (mtDNA) haplogroups are ancestry-related patterns of single nucleotide polymorphisms that have been associated with neurodegenerative diseases in HIV-uninfected populations, and with HIV- and CART-associated outcomes. We hypothesized that mtDNA haplogroups are associated with NCI in…

Development of Tuberculosis in HIV-Infected Patients Receiving Successful TARGA

Background: The incidence of active tuberculosis in HIV-infected patients receiving antiretroviral therapy (ART) is still significantly higher than that observed in the general population. We hypothesized that an optimal immunological recovery may reduce the risk of tuberculosis. Methodology: Historical cohort study in ART-treated patients without previous diagnosis of tuberculosis. Tuberculosis was diagnosed only if microbiologically…

Increased Risk of TB and Persistent Immune Deficit With Delayed ART: A Randomized Trial From Haiti

Background: The long-term (5 year) effect of early initiation of antiretroviral therapy (ART) versus delayed initiation of ART on immune recovery and risk for tuberculosis (TB) infection in HIV-1 infected individuals is not certain. Methodology: We conducted an open label randomized controlled trial of immediate initiation of ART in HIV-infected adults with CD4 counts between…

Timeliness of ART Initiation Among HIV-Infected Patients With TB in Sub-Saharan Africa

Background: Initiating antiretroviral therapy (ART) early during TB treatment increases survival among people living with HIV (PLWH). 2010 WHO guidelines recommend ART initiation for PLWH as soon as possible after TB treatment initiation, regardless of CD4+ count. Yet, globally, only 48% of PLWH with TB were on ART in 2011. Methodology: We used routinely-collected data…

Impacts of National ART Initiation Policy Change on Integrated TB HIV Practice in Zomba Malawi

Background: In response to emerging evidence for the safety and clinical benefit of early Antiretroviral (ART) initiation in tuberculosis (TB) patients, the National TB Programme (NTP) in Malawi implemented a change in policy for TB patients co-infected with Human Immunodeficiency Virus (HIV) in September 2011. Clinicians were advised to start ART as soon as possible,…

Does Long-term ART Reduce TB Rates to Background Population Levels? Data From a National HIV Cohort

Background: Antiretroviral therapy (ART) promotes immune reconstitution and is associated with a time-dependent reduction in HIV-associated tuberculosis (TB) incidence. It is not known if TB rates in individuals on long-term ART remain elevated compared to the background population, particularly in low TB prevalence areas. Methodology: National HIV positive cohort records were linked to the national…

Depleted DHEA-S Reserves Are Associated With Early Mortality After ART Initiation in HIV/TB

Background: Early mortality post-ART initiation in advanced HIV/TB co-infection is associated with poor pathogen-specific immunologic recovery despite virologic suppression. The active form of dehydroepiandrosterone-sulfate (DHEA-S), DHEA, an adrenal androgen, enhances Th1 responses in HIV/TB and is available as an over-the-counter supplement. We hypothesized that low pre-ART (baseline) DHEA-S levels are associated with early mortality in…